Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

649 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 102
Recruiting: 49
Ph III recruiting: 2
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (104)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07383298	Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase	enrolling by invitation	—	100	Qian JiangOTHER	1	Feb 3, 2026	clinicaltrials
NCT06646978	Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial(K2SPIRIT)	enrolling by invitation	—	787	Poitiers University HospitalOTHER